FAM107B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.147000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.970400E-01
Normal-vs-Stage2
4.322600E-01
Normal-vs-Stage3
1.702380E-01
Normal-vs-Stage4
4.321400E-01
Stage1-vs-Stage2
5.234200E-01
Stage1-vs-Stage3
3.808200E-01
Stage1-vs-Stage4
6.518000E-01
Stage2-vs-Stage3
4.829200E-01
Stage2-vs-Stage4
9.166800E-01
Stage3-vs-Stage4
4.234200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.839200E-01
Normal-vs-AfricanAmerican
8.750800E-01
Normal-vs-Asian
4.923400E-01
Caucasian-vs-AfricanAmerican
1.201000E-01
Caucasian-vs-Asian
7.678400E-01
AfricanAmerican-vs-Asian
3.231800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.321000E-01
Normal-vs-Female
5.260000E-01
Male-vs-Female
3.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.193400E-01
Normal-vs-Age(41-60Yrs)
5.035000E-01
Normal-vs-Age(61-80Yrs)
3.995800E-01
Normal-vs-Age(81-100Yrs)
4.011800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.691400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.118800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.139000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.023200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.854600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.117000E-01
Normal-vs-Daily Drinker
2.498000E-01
Normal-vs-Weekly Drinker
2.010800E-01
Normal-vs-Occasional Drinker
6.220800E-01
Normal-vs-Social Drinker
6.803900E-02
Non Drinker-vs-Daily Drinker
5.094600E-01
Non Drinker-vs-Weekly Drinker
5.212200E-01
Non Drinker-vs-Occasional Drinker
6.394400E-01
Non Drinker-vs-Social Drinker
3.770200E-01
Daily Drinker-vs-Weekly Drinker
9.783600E-01
Daily Drinker-vs-Occasional Drinker
3.779600E-01
Daily Drinker-vs-Social Drinker
8.618400E-01
Weekly Drinker-vs-Occasional Drinker
4.152000E-01
Weekly Drinker-vs-Social Drinker
8.814000E-01
Occasional Drinker-vs-Social Drinker
2.854200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.488550E-01
Normal-vs-Grade 2
2.086400E-02
Normal-vs-Grade 3
4.035300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.661400E-01
Grade 1-vs-Grade 3
2.750400E-01
Grade 1-vs-Grade 4
1.488550E-01
Grade 2-vs-Grade 3
1.388120E-02
Grade 2-vs-Grade 4
2.086400E-02
Grade 3-vs-Grade 4
4.035300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.076000E-01
Normal-vs-NonDiabetic
2.842600E-01
Diabetic-vs-NonDiabetic
5.469000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.739400E-01
Normal-vs-NoPancreatitis
3.188000E-01
Pancreatitis-vs-NoPancreatitis
9.552000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.341000E-01
Normal-vs-N1
3.769600E-01
N0-vs-N1
9.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.538200E-01
Normal-vs-TP53-NonMutant
5.734800E-01
TP53-Mutant-vs-TP53-NonMutant
5.902000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
